COVID Meets IBD: What We Know About the Vaccine
Vaccines are on everyone’s mind these days, as we hope to resume a normal life without the worries of the coronavirus shortly. But what does this mean for those living with Inflammatory Bowel Disease? What do we know about the SARS-CoV-2 vaccine when it comes to IBD?
An evening hosted by the ±«ÓãÖ±²¥ IBD Research Group, Dr. Gilaad Kaplan, Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of Calgary and co-chair of Crohn’s and Colitis Canada’s COVID-IBD Taskforce who, to date, have organized for the IBD community, will discuss the impact of COVID-19 on those living with IBD and recent recommendations on the coronavirus vaccine.
Moderator: Dr. Peter Lakatos, Professor of Medicine and Director of the IBD Centre at the ±«ÓãÖ±²¥ Health Centre (MUHC).
For more info and to register, click .